About Insulet Corporation

Insulet Corporation , headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas.

CEO

Shacey Petrovic

Employees

1900

Headquarters

100 Nagog Park
Acton, Massachusetts 01720-3440
Phone: 19786007000
www.myomnipod.com

News

Navigate the Future of Healthcare with Comprehensive Insights on the Expanding Implantable Infusion Pumps Market
Sep 29, 2023 16:00pm

Source:Kwhen Finance

Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
Sep 28, 2023 10:00am

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the third quarter of 2023 on November 2, 2023 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time). The link to the live call will be available on the Investor

Source:Business Wire

Insulet''s financial journey marked by Fed rate hikes and new diabetes treatments
Sep 27, 2023 05:22am

https://www.investing.com/news/stock-market-news/insulets-financial-journey-marked-by-fed-rate-hikes-and-new-diabetes-treatments-93CH-3183581

Source:Investing.com

Insulet (PODD)''s True Worth: A Comprehensive Analysis of Its Market Value
Sep 26, 2023 23:32pm

Insulet (PODD)''s True Worth: A Comprehensive Analysis of Its Market Value

Source:GuruFocus

Insulet, Tandem Diabetes drop as weight loss drugs impact insulin use
Sep 07, 2023 17:38pm

Shares of Insulet (PODD) and Tandem Diabetes (TNDM) fell Thursday after data indicated that popular weight loss drugs cut insulin injections in diabetes. Read more here.

Source:Seeking Alpha

Why Insulet Stock Is Sinking Today
Sep 07, 2023 16:34pm

Comments from Insulet''s CEO at a major healthcare conference rattled investors.

Source:The Motley Fool

Why Insulet Stock Rocked the Market Today
Aug 30, 2023 22:46pm

The company''s leader signals a giant vote of confidence in its future.

Source:The Motley Fool

Stocks making the biggest moves midday: HPQ, BOX, BF.B, PODD
Aug 30, 2023 16:32pm

The post Stocks making the biggest moves midday: HPQ, BOX, BF.B, PODD appeared on BitcoinEthereumNews.com . The logo of the 3D printer manufacturer HP is seen during the event. Feria de Barcelona hosts the third edition of the (3D) industry week. Paco Freire | LightRocket |…

Source:Bitcoin Ethereum News

Stocks making the biggest moves midday: HP, Box, Brown-Forman, Insulet and more
Aug 30, 2023 16:21pm

These are the stocks posting the largest moves in midday trading.

Source:CNBC

President and CEO of Insulet Makes $1.01M Buy
Aug 30, 2023 15:03pm

James Hollingshead , President and CEO at Insulet (NASDAQ: PODD ), reported a large insider buy on August 29, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Hollingshead purchased 5,550 shares of Insulet. The total transaction amounted to $1,006,825. Insulet shares are trading up 7.41% at $203.51 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. The Importance of Insider Transactions Insider transactions shouldn''t be used primarily to make … Full story available on Benzinga.com

Source:Benzinga